Treatment of IL-18-binding protein biologics suppresses fibrotic progression in metabolic dysfunction-associated steatohepatitis

Albumin-binding recombinant human IL-18BP ameliorates macrophage activation syndrome and atopic dermatitis via direct IL-18 inactivation

Disruption of IL-18 signaling via engineered IL-18BP biologics alleviates experimental cholestatic liver disease

Structural basis of serum albumin recognition by SL335, an antibody Fab extending the serum half-life of protein therapeutics

Intact bioactivities and improved pharmacokinetic of the SL335-IFN-beta-1a fusion protein that created by genetic fusion of SL335, a human anti-serum albumin fab, and human interferon-beta

Optimal expression of a Fab-effector fusion protein in Escherichia coli by removing the cysteine residues responsible for an interchain disulfide bond of a Fab molecule

Isolation of human anti-serum albumin Fab antibodies with an extended serum-half life

Involvement of Src and the actin cytoskeleton in the antitumorigenic action of adenosine dialdehyde

Anti-inflammatory activity of ethanol extract derived from Phaseolus angularis beans

Isolation of human Fab antiodies specific for the low-affinity IgE receptor (CD23) by selecting a hierachical antibody library system against B lymphoblastic IM-9 cells